Hôtel-Dieu de Québec
11 Côte du Palais
Québec, QC
Canada G1R 2J6
Dernières nouvelles
Information non disponible
- Aloui, MalekEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67530malek.aloui@crchudequebec.ulaval.ca
1401, 18e rue
G3.457
Québec, QC
Canada G1J 1Z4 - Anderson, AudreyEmployé+1 418-525-4444, poste 67513
- Becerra Perez, Maria MargaritaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67526Maria-Margarita.Becerra-Perez@crchudequebec.ulaval.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Bergeron, Karol-AnneEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67315
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Bordeleau, SophieEmployé
- Bouchard, AnnickEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67314annick.bouchard@crchudequebec.ulaval.ca
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Boudreault, Marie-NicoleEmployéL'Hôtel-Dieu de Québecmarie-nicole.boudreault@crchudequebec.ulaval.ca
9 rue McMahon
Québec, QC
Canada G1R 3S3 - Bradley, MélanieEmployéHôpital Saint-Sacrement
1050, chemin Sainte-Foy
Québec, Québec
Canada G1S 4L8Hôpital de l'Enfant-Jésus+1 418-525-4444, poste 67525+1 418-691-5065melanie.bradley@chudequebec.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Brochu, Marie-PierreEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67512marie-pierre.brochu@chudequebec.camarie-pierre.brochu@crchudequebec.ulaval.ca
1401, 18e rue
G2.460
Québec, QC
Canada G1J 1Z4 - Chabot, PatriciaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67310patricia.chabot@chudequebec.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Ezzine, HoudaEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67542houda.ezzine@chudequebec.ca
1401, 18e rue
G3.514
Québec, QC
Canada G1J 1Z4 - Gingras, MaryseEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67322maryse.gingras@chudequebec.ca
1401, 18e rue
G2.468
Québec, QC
Canada G1J 1Z4 - Gyejacquot, SophieEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67540sophie.gyejacquot@chudequebec.casophie.gyejacquot@crchudequebec.ulaval.ca
1401, 18e rue
G3.514
Québec, QC
Canada G1J 1Z4 - Lavoie, SandyEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67309+1 418-691-5065sandy.lavoie.1@ulaval.caSandy.Lavoie@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Marcotte, CatherineEmployécatherine.marcotte@crchudequebec.ulaval.ca
- Métivier-Pinard, JulieEmployéHôpital de l'Enfant-Jésus+1 418-525-4444julie.metivier-pinard@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - Nadeau, BiancaEmployé+1 418-525-4444bianca.nadeau@crchudequebec.ulaval.ca
- Ndayizigiye, AliceEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67308alice.ndayizigiye.1@ulaval.caAlice.Ndayizigiye@crchudequebec.ulaval.ca
1401, 18e rue
G2.457
Québec, QC
Canada G1J 1Z4 - St-Pierre, DominiqueEmployéHôpital de l'Enfant-Jésus+1 418-525-4444, poste 67524Dominique.St-Pierre@chudequebec.cadspierre@crchudequebec.ulaval.ca
1401, 18e rue
G3.453
Québec, QC
Canada G1J 1Z4 - Villemure, IsabelleEmployéHôpital de l'Enfant-Jésusisabelle.villemure@crchudequebec.ulaval.ca
1401, 18e rue
G2.456
Québec, QC
Canada G1J 1Z4
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI
Article de revueFront Oncol, 9 , 2019.
Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients
Article de revueSci Rep, 9 (1), 2019.
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)
Article de revueJ Thorac Oncol, 14 (9), 2019.
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Article de revueNat Med, 25 (6), 2019.
Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients
Article de revuePharmacogenomics, 20 (17), 2019.
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
Article de revueFront Pharmacol, 9 , 2018.
Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial
Article de revueAdv Ther, 34 (1), 2017.
Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L
Article de revueFront Pharmacol, 8 , 2017.
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial
Article de revueLancet Oncol, 17 (2), 2016.
nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial
Article de revueAdv Ther, 33 (5), 2016.
Projets actifs
- Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly diagnosed metastatic pancreatic adenocarcinoma: a feasibility and proof-of-concept study, du 2019-10-01 au 2025-03-31